Health related quality of life among both current and former injection drug users who are HIV-infected

Drug and Alcohol Dependence

Volumn 86, Issue 2-3, 2007, Pages 175-182

  Préau, Marie ^a,b   Protopopescu, Camélia ^a   Spire, Bruno ^a   Sobel, Alain ^c   Dellamonica, Pierre ^d   Moatti, Jean Paul ^a   Carrieri, M Patrizia ^a  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

HAART; Health related quality of life; HIV; Injecting drug users; Negative life events; Substitution treatment

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL CARE; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SOCIAL SUPPORT; VIOLENCE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIARRHEA; FEMALE; HIV INFECTIONS; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33751416851     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.06.012     Document Type: Article

References (45)

1. Allardice G.M., Mcmenamin J.J., Parpia T., Gibbs J., Mcsharry C., and Whitelaw J. The recent impact of antiretroviral combination therapy on CD4 counts, AIDS and death in HIV-infected persons: routine HIV surveillance in Scotland. Int. J. STD AIDS 9 (1998) 561-566
2. Bissell L., and Skorina J.K. One hundred alcoholic women in medicine. An interview study. JAMA 257 (1987) 2939-2944
3. Bouhnik A.D., Carrieri M.P., Rey D., Spire B., Gastaut J.A., Gallais H., and Obadia Y. Drug injection cessation among HIV-infected injecting drug users. Addict. Behav. 29 (2004) 1189-1197
4. Bouhnik A.D., Chesney M., Carrieri P., Gallais H., Moreau J., Moatti J.P., Obadia Y., and Spire B. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J. Acquir. Immune. Defic. Syndr. 31 Suppl. 3 (2002) S149-S153
5. Bouhnik A.D., Preau M., Vincent E., Carrieri M.P., Gallais H., Lepeu G., Gastaut J.A., Moatti J.P., and Spire B. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir. Ther. 10 (2005) 53-61
6. Bruneau J., Brogly S.B., Tyndall M.W., Lamothe F., and Franco E.L. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction 99 (2004) 727-737
7. Burack J.H., Barrett D.C., Stall R.D., Chesney M.A., Ekstrand M.L., and Coates T.J. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA 270 (1993) 2568-2573
8. Burgoyne R., and Renwick R. Social support and quality of life over time among adults living with HIV in the HAART era. Soc. Sci. Med. 58 (2004) 1353-1366
9. Carrieri M.P., Moatti J.P., Vlahov D., Obadia Y., Reynaud-Maurupt C., and Chesney M. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. J. Epidemiol. Community Health 53 (1999) 4-8
10. Carrieri P., Spire B., Duran S., Katlama C., Peyramond D., Francois C., Chene G., Lang J.M., Moatti J.P., and Leport C. Health-related quality of life after 1 year of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 32 (2003) 38-47
11. Cascade T., and Collaboration. Survival after introduction of HAART in people with known duration of HIV-1 infection. The Lancet 355 (2000) 1158-1159
12. Ciesla J.A., and Roberts J.E. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am. J. Psychiatry 158 (2001) 725-730
13. Cunningham W.E., Crystal S., Bozzette S., and Hays R.D. The association of health-related quality of life with survival among persons with HIV infection in the United States. J. Gen. Intern Med. 20 (2005) 21-27
14. Dalgard O., Egeland A., Skaug K., Vilimas K., and Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology 39 (2004) 74-80
15. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 51 (1998) 253-263 (discussion 267-268)
16. Duran S., Spire B., Raffi F., Walter V., Bouhour D., Journot V., Cailleton V., Leport C., and Moatti J.P. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin. Trials 2 (2001) 38-45
17. Fuhrer R., and Rouillon F. La version française de l'échelle CES-D. Description and translation of the autoevaluation scale (in French). Psychiatrie et Psychobiologie 4 (1989) 163-166
18. Gandek B., Ware Jr. J.E., Aaronson N.K., Alonso J., Apolone G., Bjorner J., Brazier J., Bullinger M., Fukuhara S., Kaasa S., Leplege A., and Sullivan M. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J. Clin. Epidemiol. 51 (1998) 1149-1158
19. Gielen A.C., Mcdonnell K.A., Wu A.W., O'campo P., and Faden R. Quality of life among women living with HIV: the importance violence, social support, and self care behaviors. Soc. Sci. Med. 52 (2001) 315-322
20. Grant I., Mohns L., Miller M., and Reitan R.M. A neuropsychological study of polydrug users. Arch. Gen. Psychiatry 33 (1976) 973-978
21. Greenfield L., Bigelow G.E., and Brooner R.K. Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors. Drug Alcohol Depend 39 (1995) 91-98
22. Guyatt G.H., and Jaeschke R.J. Reassessing quality-of-life instruments in the evaluation of new drugs. Pharmacoeconomics 12 (1997) 621-626
23. Jia H., Uphold C.R., Wu S., Reid K., Findley K., and Duncan P.W. Health-related quality of life among men with HIV infection: effects of social support, coping, and depression. AIDS Patient Care STDS 18 (2004) 594-603
24. Johnson J.G., Rabkin J.G., Lipsitz J.D., Williams J.B., and Remien R.H. Recurrent major depressive disorder among human immunodeficiency virus (HIV)-positive and HIV-negative intravenous drug users: findings of a 3-year longitudinal study. Compr. Psychiatry 40 (1999) 31-34
25. Knowlton A., Hua W., and Latkin C. Social support among HIV positive injection drug users: implications to integrated intervention for HIV positives. AIDS Behav. 8 (2004) 357-363
26. Knowlton A.R., Hua W., and Latkin C. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention. AIDS Care 17 (2005) 479-492
27. Latkin C.A., Knowlton A.R., Hoover D., and Mandell W. Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: a prospective study. Am. J. Drug. Alcohol Abuse 25 (1999) 463-473
28. Latkin C.A., and Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction 93 (1998) 1191-1197
29. Litwin A.H., Soloway I., and Gourevitch M.N. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clin Infect Dis. 40 Suppl. 5 (2005) S339-S345
30. Lyketsos C.G., Hoover D.R., Guccione M., Senterfitt W., Dew M.A., Wesch J., Vanraden M.J., Treisman G.J., and Morgenstern H. Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study. JAMA 270 (1993) 2563-2567
31. Marimoutou C., Carrieri P., Poizot-Martin I., Loundou A., Tremolieres F., Rey D., and Obadia Y. Hospitalization for depressive syndrome in a cohort of HIV-infected patients contaminated through injecting drug use: MANIF 2000 cohort, France, 1995-1999. AIDS Care 15 (2003) 729-734
32. McDonnell K.A., Gielen A.C., O'campo P., and Burke J.G. Abuse HIV status and health-related quality of life among a sample of HIV positive and HIV negative low income women. Qual. Life Res. 14 (2005) 945-957
33. McNaghten A.D., Hanson D.L., Dworkin M.S., and Jones J.L. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J. Acquir. Immune. Defic. Syndr. 32 (2003) 499-505
34. Messiah A., Loundou A.D., Maslin V., Lacarelle B., and Moatti J.P. Physician recognition of active drug use in HIV-infected patients is lower than validity of patient's self-reported drug use. J. Pain Symptom Manage. 21 (2001) 103-112
35. Moatti J.P., Carrieri M.P., Spire B., Gastaut J.A., Cassuto J.P., and Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 Study Group. AIDS 14 (2000) 151-155
36. Moore R.D., Keruly J.C., and Chaisson R.E. Differences in HIV disease progression by injecting drug use in HIV-infected persons in care. J. Acquir. Immune. Defic. Syndr. 35 (2004) 46-51
37. Preau M., Leport C., Salmon-Ceron D., Carrieri P., Portier H., Chene G., Spire B., Choutet P., Raffi F., and Morin M. Health-related quality of life and patient-provider relationships in HIV-infected patients during the first 3 years after starting PI-containing antiretroviral treatment. AIDS Care 16 (2004) 649-661
38. Preau M., Vincent E., Spire B., Reliquet V., Fournier I., Michelet C., Leport C., and Morin M. Health-related quality of life and health locus of control beliefs among HIV-infected treated patients. J. Psychosom. Res. 59 (2005) 407-413
39. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Measure. 3 (1977) 385-491
40. Sabin C.A. The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era. AIDS 16 Suppl. 4 (2002) S61-S68
41. Safren S.A., Radomsky A.S., Otto M.W., and Salomon E. Predictors of psychological well-being in a diverse sample of HIV-positive patients receiving highly active antiretroviral therapy. Psychosomatics 43 (2002) 478-485
42. Shor-Posner G., Lecusay R., Miguez-Burbano M.J., Quesada J., Rodriguez A., Ruiz P., O'mellan S., Campa A., Rincon H., Wilkie F., Page J.B., and Baum M.K. Quality of life measures in the Miami HIV-1 infected drug abusers cohort: relationship to gender and disease status. J. Subst. Abuse 11 (2000) 395-404
43. te Vaarwerk M.J., and Gaal E.A. Psychological distress and quality of life in drug-using and non-drug-using HIV-infected women. Eur. J. Public Health 11 (2001) 109-115
44. Tostes M.A., Chalub M., and Botega N.J. The quality of life of HIV-infected women is associated with psychiatric morbidity. AIDS Care 16 (2004) 177-186
45. White J.M. Pleasure into pain: the consequences of long-term opioid use. Addict. Behav. 29 (2004) 1311-1324